Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000920465-14-000091)

Filing Details

Accession Number:: 0000920465-14-000091
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-08-05 17:31:44
Reporting Period:: 2014-07-31

Filing Date:: 2014-08-05
Accepted Time:: 2014-08-05 17:31:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
920465	La Jolla Pharmaceutical Co	LJPC	Biological Products, (No Disgnostic Substances) (2836)	330361285

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1495521	Saiid Zarrabian	4660 La Jolla Village Drive Suite 1070 San Diego CA 92122		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-07-31	381	$9.53	381	No	4	P	Indirect	For Children

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	For Children

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	109,231	Direct

Footnotes

Represents the weighted-average price at which shares were purchased within a range between $9.52 and $9.60. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.